Australia's Provectus Algae closes Series A Extension as breakthrough programmes move toward commercial scale
Singapore, Nov. 18 -- Provectus Algae, the Australian biotechnology startup using advanced biomanufacturing to develop next-generation biological products, has closed a $4.3 million extension to its Series A financing, bringing total Series A funding to more than $14 million.
The Series A was led by At One Ventures, with the extension welcoming Queensland Investment Corporation (QIC) as a new investor, including through the Queensland Government's A$30 million Sowing the Seeds of Farming Innovation Fund, managed by QIC, alongside continued support from existing shareholders.
The additional investment follows a period of significant technical and commercial progress for Provectus Algae, with programmes developed through its Precision Pho...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.